XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound =O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US15547999P external-priority Application filed by Santana Nottage filed Critical Santana Nottage Priority to US09/666,383 priority Critical patent/US6273284B1/en Application granted granted Critical Publication of US6273284B1 publication Critical patent/US6273284B1/en Anticipated expiration legal-status Critical Status Expired - Fee Related legal-status Critical Current Links Original Assignee Santana Nottage Priority date (The priority date is an assumption and is not a legal conclusion. ![]() Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Fee Related Application number US09/666,383 Inventor Santana Lavon Nottage Current Assignee (The listed assignees may be inaccurate. If you want to be part of the next chapter, contact us today.Download PDF Info Publication number US6273284B1 US6273284B1 US09/666,383 US66638300A US6273284B1 US 6273284 B1 US6273284 B1 US 6273284B1 US 66638300 A US66638300 A US 66638300A US 6273284 B1 US6273284 B1 US 6273284B1 Authority US United States Prior art keywords plate units centered latch apertured Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. When it happens, Micromate™ users will also be able to achieve the same reported submillimeter accuracy under CT, Ultrasound, and/or Optical Navigation guidance. Over the next 9 months, along with installing more reference sites in Europe and expanding to other key geographies, we are going to launch our full-fledged surgical platform. Innovation is at the core of our strategy, as it is making our cutting-edge technology available everywhere, for as many applications as possible. The one-month follow-up appointments with the patients confirmed the successful outcomes. Several more surgeries took place since that day, all with 100% accuracy and no reported pedicle breach events. Integrated into the Fusion Robotics system – which also includes a navigation station and an instrument set – Micromate™ assisted on the execution of a single-level minimally invasive transforaminal lumbar interbody fusion (MI-TLIF), including the placement of pedicle screw fixation guided by the robot. Kevin Foley, at Baptist Memorial Hospital, in Memphis, TN, completed the first spine fusion procedure using Micromate™. This versatile, modular surgical platform was also adopted by strategic partners looking to support robotic-guided procedures for different applications. ![]() No complications have been reported, and a 100% diagnostic yield and accuracy have been attained on biopsy procedures.Ī modular surgical platform for minimally invasive surgery These results are based on reported data from procedures conducted in 10 body regions, some particularly critical: Femur, Liver, Thoracic Spine, Lumbar Spine, Aorta, Lung, Ovaries, Ilium-sacrum, Sternum, and the Parotid Gland. In the reported cases, Micromate™ supported 0.43 ± 0.5mm average accuracy of alignment to the trajectory and 0.79 ± 0.41º average angular accuracy of needle guidance from entry to target location. Quickly approaching 100 procedures, Micromate™ has confirmed its capability of supporting submillimeter accuracy from head to toe. Nine months have passed since that first installation, and the clinical results obtained with the system by the reference sites in The Netherlands, Austria, and Switzerland are remarkable. ![]() The highest accuracy with no complications Antonius Ziekenhuis, in Nieuwegein, The Netherlands. ![]() The first ever Micromate™ user has been Dr. In what has been an unusual year for the MedTech industry, Micromate™ performed substantially well: unveiled to the world in Spring 2020, it obtained its CE-Mark in early Summer, and started its clinical use in early Fall.
0 Comments
Leave a Reply. |